Defined Wealth Management, LLC Biogen Inc. Transaction History

Defined Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$190.52 - $236.72 $173,373 - $215,415	910 New	910 $210,000
Q4 2023 Jan 09, 2024	BUY	$222.59 - $267.94 $445 - $535	2 Added 0.21%	933 $241,000
Q3 2023 Oct 24, 2023	BUY	$253.3 - $285.89 $1,266 - $1,429	5 Added 0.54%	931 $239,000
Q2 2023 Jul 28, 2023	BUY	$275.25 - $318.06 $275 - $318	1 Added 0.11%	926 $263,000
Q4 2022 Jan 23, 2023	SELL	$252.44 - $306.72 $50,488 - $61,344	-200 Reduced 17.78%	925 $0
Q2 2022 Jul 25, 2022	SELL	$187.54 - $223.02 $2,625 - $3,122	-14 Reduced 1.23%	1,125 $229,000
Q3 2021 Oct 21, 2021	BUY	$282.99 - $369.05 $3,961 - $5,166	14 Added 1.24%	1,139 $322,000
Q1 2021 May 18, 2021	SELL	$242.95 - $284.63 $5,344 - $6,261	-22 Reduced 1.92%	1,125 $315,000
Q4 2020 Mar 09, 2021	BUY	$236.26 - $355.63 $270,990 - $407,907	1,147 New	1,147 $281,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Defined Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Defined Wealth Management, LLC with notifications on news.